Bizma Investimentos Ltda Gilead Sciences, Inc. Transaction History

Bizma Investimentos Ltda

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Oct 07, 2022	SELL	$62.63 - $80.22 $10.6 Million - $13.6 Million	-170,000 Closed	0 $0
Q2 2019 Oct 07, 2022	SELL	$61.87 - $69.38 $48.2 Million - $54 Million	-778,800 Reduced 82.08%	170,000 $11.5 Million
Q1 2019 Oct 07, 2022	BUY	$62.53 - $70.05 $55 Million - $61.6 Million	880,000 Added 1279.07%	948,800 $7.32 Million
Q4 2018 Oct 07, 2022	BUY	$60.54 - $79.0 $4.17 Million - $5.44 Million	68,800 New	68,800 $4.3 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bizma Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Bizma Investimentos Ltda with notifications on news.